|
End-of-day quote
Mexican S.E.
25/09/2026
|
5-day change | 1st Jan Change | ||
| 2,572.00 MXN | +5.24% |
|
+5.24% | +2.88% |
| 30/09 | Merck's experimental skin disease drug succeeds in mid-stage study | RE |
| 30/09 | Major drugmakers turn to China for licensing deals | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NOVARTIS AG | Other Pharmaceuticals | +5.24% | +5.24% | +2.88% | +14.06% | +54.08% | 28TCr |
-
|
-
|
-
|
- Stock Market
- Stocks
- NOVN Stock
- NVS N Stock
- Charts Novartis AG
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
